July 24, 2018
2 min watch
Save

VIDEO: ProQR develops RNA treatments aimed at rare diseases

VANCOUVER, British Columbia Daniel de Boer, CEO of ProQR, discusses the company’s ophthalmology pipeline, including QR-110 for Leber’s congenital amaurosis type 10 presented during the Foundation Fighting Blindness Emerging Science Showcase at OIS Retina.